Month: September 2019

Eagle Bulk Shipping Inc. Takes Delivery of M/V Dublin Eagle

Posted on by Admin

Eagle Bulk Shipping Inc. Takes Delivery of M/V Dublin Eagle

STAMFORD, Conn.,, Sept. 11, 2019 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk” or the “Company”), one of the world’s largest owner-operators within the Supramax / Ultramax segment, today announced that it has taken delivery of the first of six modern Ultramax drybulk vessels the Company has previously agreed to acquire.

The ship, which has been renamed the M/V Dublin Eagle, is a 2015-built, high specification scrubber-fitted SDARI-64 Ultramax vessel built at Jiangsu New Hantong Ship Heavy Industry Co., Ltd.

Proforma for the five remaining acquisition vessels, which have yet to be delivered, the Company’s fleet will total 50 ships, including 20 Ultramax drybulk vessels acquired over the last 36 months.

About Eagle Bulk Shipping Inc.

Eagle Bulk Shipping Inc. (“Eagle” or the “Company”) is a US-based fully integrated shipowner-operator providing global transportation solutions to a diverse group of customers including miners, producers, traders, and end users. Headquartered in Stamford, Connecticut, with offices in Singapore and Copenhagen, Eagle focuses exclusively on the versatile mid-size drybulk vessel segment and owns one of the largest fleets of Supramax/Ultramax vessels in the world. The Company performs all management services in-house (including: strategic, commercial, operational, technical, and administrative) and employs an active management approach to fleet trading with the objective of optimizing revenue performance and maximizing earnings on a risk-managed basis. For further information, please visit our website: www.eagleships.com.

Company Contact:
Frank De Costanzo
Chief Financial Officer
Eagle Bulk Shipping, Inc.
Tel. +1 203-276-8100

Media Contact:
Rose & Company
Tel. +1 212-359-2228

Cyclical Economic Shifts: Industrial Companies Could Feel the Effects

Posted on by Admin

Cyclical Economic Shifts: Industrial Companies Could Feel the Effects

The Industrial sector provides numerous products and services that support many industries and companies. Industrial companies manufacture construction machinery and equipment, aircraft, and provide commercial and transportation services. Investing in industrial companies allows for diversified portfolios and long-term growth with a multi-trillion-dollar market cap. Many industrial companies are cyclical, so they are affected by economic shifts.

How Can Innovations in Transportation and Logistics Provide Value to Investors?

Posted on by Admin

How Can Innovations in Transportation and Logistics Provide Value to Investors?

The transportation and logistics industry covers a broad range of sectors, such as shipping, freight, railroad, and truck transport, so investing in it provides opportunity for a diversified portfolio. Private, public, and governmental investing all help supply the necessary funding for the industry and improve the supply chain. Investment in new and public transportation systems, such as highways, streets, and airports, can provide value to both the investor and the community.

Research – Eagle Bulk Shipping (EGLE) – Signaling a Recovery

Posted on by Admin

Tuesday, September 10, 2019

Eagle Bulk Shipping (EGLE)

Several Signs of Recovery Ahead

Eagle Bulk Shipping (EGLE) moves both major and minor dry bulk around the world. Adjusting for announced transactions, EGLE operates a fleet of 50 dry bulk vessels and transports bulk commodities, including coal, grain, iron ore, steel, cement, forest products, and other raw and finished materials. The current fleet consists of 16 Ultramax and 29 Supramax class dry bulk vessels, or mid-sized assets. After the latest acquisition of six Ultramaxes and the sale of one Supramax close in 3Q2019, there will be 20 Ultramaxes and 30 Supramaxes in the fleet. Ultramaxes are larger versions of Supramaxes and carry about 63k deadweight tons (DWT) and Supramaxes carry between 50k and 59k dwt.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

  • Dry bulk market has firmed in 3Q2019 despite trade tension overhang.  There were clearly near-term challenges to the dry bulk market earlier this year due to trade tensions and slower global economic growth. However, dry bulk indices have improved in the past quarter and are currently near multi-year highs.
  • Acquisition update. Fleet expands and age profile improves.   The acquisition of six high-spec. SDARI-64 Ultramaxes in two transactions for ~$122 million is…



    Get full report on Channelchek desktop.


Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Will the Longest Economic Expansion in History Continue?

Posted on by Admin

Will the Longest Economic Expansion in History Continue?

Job growth in the United States slowed more than expected in August. The U.S. labor market has been a key positive player amid weakening global economic data, but the most recent report is shaky. The Federal Reserve is expected to cut interest rates again this month to keep the expansion on track. 

Will Renewable Energy be the Downfall of Fossil Fuels?

Posted on by Admin

Will Renewable Energy be the Downfall of Fossil Fuels?

Fossil fuel has been the main energy source since the mid-1700s during the Industrial Revolution. It has provided the majority of our power since then, but research shows that when burned, it has negative impacts on the environment. For this reason, many countries have been searching for an alternative, preferably a renewable one. Solar and wind power have been the most prominent choices and have seen a jump in popularity in recent years.

Can Investing in Natural Resources Provide Future Value?

Posted on by Admin

Can Investing in Natural Resources Provide Future Value?

Investing in natural resources can provide value as demand for resources such as lumber, precious metals, coal, and water will always exist. Natural resources are core to production, comprising many processed goods. Natural resource companies that either process or supply these resources will be in constant demand as the world population grows and expands. Investing in natural resources requires an understanding of a broad range of processes and extraction companies. Natural resources can be collected in a variety of forms and further processed, packaged, and sold by companies.

Are the Trade Troubles Coming to an End?

Posted on by Admin

Are the Trade Troubles Coming to an End?

For the past two years, President Donald Trump has been battling China in an attempt to create a mutually beneficial trade relationship. The two sides have continued to create significant disagreements in this drawn-out dispute, which has caused issues for both economies. Yet the markets have surprisingly bounced back each time. The increase has spiked investors’ confidence, but they are still waiting on a final deal.

Prescription Drug Pricing: How Would Limited Government Intervention Change the Landscape?

Posted on by Admin

Prescription Drug Pricing: How Would Limited Government Intervention Change the Landscape?

Bringing down prescription drug prices has been a campaign promise by many presidents over the years. Making a deal with the pharmaceutical companies is not an easy task, as these companies operate just like any other, with a goal to maximize profit. Big Pharma companies produce drugs that save people’s lives, which comes with a price many who need it cannot afford, even with health insurance. Government deregulation could open the doors for other generic brands to enter the market and potentially drive down the costs of high-demand drugs. Smallcap companies in the sector would then be exposed to fair competition, rather than not standing a chance at all against pharmaceutical giants.

Utility Stocks May Offer Low-Risk Investment Potential

Posted on by Admin

Utility Stocks May Offer Low-Risk Investment Potential

Utility companies and their respective stocks can provide investors with a low-risk investment and unique advantage. Income investors can purchase smallcap utility company stocks, which are often undervalued and can provide long-term gains. Utility stocks tend to be lower risk and, much like conservative investments such as bonds, allow investors to take advantage of their higher dividend payouts.

Everything from A-to-Z: There are Consumer Cyclical Stocks for Everyone

Posted on by Admin

Everything from A-to-Z: There are Consumer Cyclical Stocks for Everyone

The consumer cyclical sector includes a broad range of companies all the way from automotive to travel and leisure. Their stocks’ performance relies on the business cycle and the current economic state. When the economy is strong and consumers have a larger disposable income, spending in these industries increases and the performance reflects in the stock price. On the other hand, when the economy contracts and consumers have less disposable income, spending on entertainment and luxuries shrinks. Remember also that company performance depends on the niche that it fills; smallcap companies in this sector are affected by the same economic conditions and business cycles as largecaps. Regarding investing, many internal and external factors must be considered when selecting the right companies for your portfolio.

Dyadic to Present at Janney Healthcare Conference

Posted on by Admin

Dyadic to Present at Janney Healthcare Conference

JUPITER, FL / ACCESSWIRE / September 4, 2019 / Dyadic International, Inc. (the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, today announced that its President and Chief Executive Officer, Mark Emalfarb will be presenting at Janney Healthcare Conference:

Date: Monday, September 9, 2019
Presentation Time: 9:55 a.m. ET
Webcast Dial-In: U.S. & Canada Toll-Free 888-223-4954
Webcast Web Login: https://cc.callinfo.com/registration/#/?meeting=16eiy2ys5xd7m&campaign=1kvxafep0di9o
Location: The Union League Club – NYC

Mr. Emalfarb will be available during the event for one-one-one meetings. Interested investors and industry partners may request a one-on-one meeting at jlatiuk@dyadic.com or contact Dyadic at (561) 743-8333.

About
Dyadic International

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1. The C1 microorganism, which enables the development and large scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (such as virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Recently, Dyadic has also begun exploring the use of its C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of Adeno-associated viral vectors (AAV), certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to create synergy by leveraging Dyadic’s technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and as a result improve access and cost to patients and the healthcare system, and most importantly, save lives.

Please visit Dyadic’s website at http://www.dyadic.com/ for additional information, including details regarding Dyadic’s plans for its biopharmaceutical business.

Safe
Harbor Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding Dyadic’s expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in Dyadic’s most recent filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. Dyadic assumes no obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled “Risk Factors” in Dyadic’s annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic’s periodic filings with the SEC, which are accessible on the SEC’s website atwww.dyadic.com.

Contact:

Dyadic International, Inc.
Ping W. Rawson
Chief Financial Officer
Phone: (561) 743-8333
Email: 
prawson@dyadic.com

SOURCE: Dyadic International, Inc.


View source version on accesswire.com: 
https://www.accesswire.com/557923/Dyadic-to-Present-at-Janney-Healthcare-Conference

News Provided by ACCESSWIRE via QuoteMedia

Treasure hunt? Let’s Talk Silver

Posted on by Admin

Treasure hunt? Let’s talk silver.

(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)

Investing in precious metals is a good way for any investor to diversify their portfolio. Precious metals, to most, primarily mean platinum, silver, and gold. From an investor standpoint, gold and silver are typically the top two choices. With silver, investors need to remember that the price is driven by market demand, and, just like gold, investors typically flock to silver for long-term holds. In comparison, however, silver is more volatile than gold but still considered a safe investment.